Glenmark Pharmaceuticals Limited logo

Glenmark Pharmaceuticals Limited

Global pharmaceutical company with 18 facilities, providing branded and generic formulations in various therapeutic areas.
1977 | Mumbai, Maharashtra (India) | Active

Last Updated:

August 04, 2024
HomeCompanyGlenmark Pharmaceuticals Limited

Who are the key members and board of directors at Glenmark Pharmaceuticals?

Executive Team (3)

NameDesignationAppointment DateStatus
Glenn Saldanha InManaging Director12-Oct-1998Current
V Mani InCFO16-Nov-2017Current
Harish Kuber InCompany Secretary02-Feb-2017Current

Board Members(7)

NameDesignationAppointment DateStatus
Vijayalakshmi Iyer In Director 14-Apr-2023Current
Dipankar Bhattacharjee Gb Director 14-Aug-2020Current
Blanche Elizabeth In Director 17-Dec-1977Current
Rajesh Desai In Director 16-May-2002Current
Cherylann Pinto In Whole-Time Director 16-May-2007Current
V Mani In Whole-Time Director and Cfo 29-May-2018Current

Financial Performance and Corporate Structure Insights of Glenmark Pharmaceuticals.

Glenmark Pharmaceuticals Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.14% increase. The company also saw a substantial fall in profitability, with a 39.49% decrease in profit. The company's net worth moved up by a moderate rise of 6.8%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
5.14%
Revenue from Operations
0.97%
Total Assets
7.29%
Profit or Loss
-39.49%
Net Worth
6.80%
EBITDA
-12.76%

Related Corporates (Common Directorship)

  • Qi Lifecare Private Limited Cn

    Qi Lifecare Private Limited Cn

    Active build-icon 25 years 3 months

    Rajesh Desai is a mutual person

  • L&T Metro Rail (Hyderabad) Limited

    L&T Metro Rail (Hyderabad) Limited

    Active build-icon 14 years 1 month

    Vijayalakshmi Iyer is a mutual person

  • Aditya Birla Capital Limited

    Aditya Birla Capital Limited

    Active build-icon 16 years 11 months

    Vijayalakshmi Iyer is a mutual person

  • Icici Securities Limited

    Icici Securities Limited

    Active build-icon 29 years 7 months

    Vijayalakshmi Iyer is a mutual person

  • Bfsi Sector Skill Council Of India

    Bfsi Sector Skill Council Of India

    Active build-icon 13 years 22 days

    Vijayalakshmi Iyer is a mutual person

  • Computer Age Management Services Limited

    Computer Age Management Services Limited

    Active build-icon 36 years 4 months

    Vijayalakshmi Iyer is a mutual person

Charges (Loans)

Open Charges Satisfied Charges

₹890.00 Cr

₹1,040.00 Cr

LenderAmountStatus

Bank Of India

Creation Date: 21 May 1985
₹890.00 CrOpen

Bank Of India

Creation Date: 29 Jul 2009
₹60.00 CrSatisfied

Axis Bank Limited

Creation Date: 18 Jun 2009
₹75.00 CrSatisfied

How Many Employees Work at Glenmark Pharmaceuticals?

Glenmark Pharmaceuticals has a workforce of 12427 employees as of Aug 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Glenmark Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Glenmark Pharmaceuticals Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.

    29 Sep 2023

  • Director Appointment

    Vijayalakshmi Rajaram Iyer was appointed as a Director was appointed as a Director on 14 Apr 2023 & has been associated with this company since 1 year 5 months .

    14 Apr 2023

  • Balance Sheet

    Glenmark Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.

    31 Mar 2023

  • Charges

    A charge registered on 23 Sep 2004 via Charge ID 80033325 with State Bank Of India was fully satisfied on 22 Jun 2022.

    22 Jun 2022

  • Charges

    A charge registered on 09 Jun 2008 via Charge ID 10114486 with Bank Of India was fully satisfied on 05 May 2022.

    05 May 2022

  • Director Appointment

    Sona Saira Ramasastry was appointed as a Director was appointed as a Director on 01 Apr 2019 & has been associated with this company since 5 years 6 months .

    01 Apr 2019

Recent News, Updates & Announcement

Frequently asked questions

  • Glenmark Pharmaceuticals Limited was incorporated on 18 Nov 1977.

  • The authorized share capital of Glenmark Pharmaceuticals Limited is ₹ 277.00 Cr and paid-up capital is ₹ 28.22 Cr.

  • Currently 10 directors are associated with Glenmark Pharmaceuticals Limited.

    • Blanche Saldanha Elizabeth
    • Rajesh Vasudeo Desai
    • Glenn Mario Saldanha
    • Cherylann Maria Pinto
    • V S Mani
    • Vijayalakshmi Rajaram Iyer
    • Sona Saira Ramasastry
    • Dipankar Bhattacharjee
    • V S Mani
    • Harish Vinayak Kuber
  • As per Ministry of Corporate Affairs (Mca), the registered address of Glenmark Pharmaceuticals Limited is B-2Mahalaxmi Chambers22 Bhulabhai Desai Road, Mumbai, Maharashtra, India, 400026.

  • The corporate identification number (CIN) of Glenmark Pharmaceuticals Limited is L24299MH1977PLC019982 and the company number is 019982 as per Ministry of Corporate Affairs (MCA).

  • Yes, Glenmark Pharmaceuticals Limited is registered on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE): GLENMARK.

  • The Official website of Glenmark Pharmaceuticals Limited is https://www.glenmarkpharma.com

  • According to the financial reports for the fiscal year 2023, the revenue trend for Glenmark Pharmaceuticals Limited has risen by 5.14%.

  • As Per 2023 financial reports, 12427 employees are currently employed by Glenmark Pharmaceuticals Limited.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Glenmark Pharmaceuticals Limited has experienced an upsurge of 6.80%.

  • As per the financial statements for fiscal Year 2023, The total open charges for Glenmark Pharmaceuticals Limited amount to ₹ 890.00 Cr.

  • The most recent Balance Sheet for Glenmark Pharmaceuticals Limited was filed with the ROC on 31 Mar 2023.

Similar Companies Based on API Manufacturers

  • Mylan Laboratories Limited
    Hyderabad, Telangana, India
  • Sun Pharmaceutical Industries Limited
    Vadodara, Gujarat, India
  • Msn Laboratories Private Limited
    K.V.Rangareddy, Telangana, India
  • Lupin Limited
    Mumbai, Maharashtra, India
  • Ipca Laboratories Limited
    Mumbai, Maharashtra, India
  • Divi'S Laboratories Limited
    K.V.Rangareddy, Telangana, India
  • Hetero Labs Limited
    K.V.Rangareddy, Telangana, India
  • Laurus Labs Limited
    Visakhapatnam, Andhra Pradesh, India
  • Cipla Limited
    Mumbai, Maharashtra, India
  • Alembic Pharmaceuticals Limited
    Vadodara, Gujarat, India
  • Gland Pharma Ltd
    Hyderabad, Telangana, India
  • Macleods Pharmaceuticals Ltd
    Mumbai, Maharashtra, India